SEC Form 4 · accession 0001104659-17-003116
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth H. Z. Fischer
Director
Period of report
Jan 17, 2017
Accepted (ET)
Jan 19, 2017 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.21 | Jan 17, 2017 | A | 10,500 | A | — | Jan 17, 2027 | Common Stock | 10,500 | 10,500 | D |
| Restricted stockF2,F3,F4 | — | Jan 17, 2017 | A | 4,500 | A | — | — | Common Stock | 4,500 | 4,500 | D |
Explanation of responses
- F1Options to purchase shares of common stock vest in 12 equal monthly installments commencing 1/31/17.
- F2Each share of restricted stock represents the right to receive, at settlement, one share of common stock.
- F3All shares of restricted stock vest on 1/17/18.
- F4Not applicable.